Ubisoft's significantly underperformed in European markets in 2024, ranking as the 47th best-selling game across the whole continent.
which was released in 2023, outsold Ubisoft's open-world adventure game despite releasing a year and a half prior. These figures were revealed by the Video Games Chronicle, which highlighted Ubisoft's struggling commercial year after a series of disappointments in 2024.
Before, Ubisoft faced shortcomings with live-service titles and, with the prior set to shut down in June 2025, and the latter having a colossal budget which led to descriptions as one of the first "AAAA" experiences. cemented a poor financial year for Ubisoft, and the association with the global sci-fi phenomenon brand hasn't assisted sales. video game adaptations have typically received critical and commercial success, with Respawn's series being a recent example of this.
However, failed to capture a similar response from fans and critics, with game-breaking bugs, clunky controls, and other technical issues leading to a middling Metacritic user score of 5.3. Despite Ubisoft's repeated fixes, patches, and DLC updates, the title didn't win audiences back over after its poor launch.
While it's important to note that released in August 2024, leaving only a few months of sales, other titles released around a similar period received excellent sales numbers, like in September. The shorter sales window compared to the charts' competitors doesn't fully excuse and 's comparative strong sales momentum in 2024 seems to reflect players' lack of trust after Ubisoft's buggy launch.